Log in to search using one of your social media accounts:

 

First patient treated with CSA Medical ’ s AV spray catheter
CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions. Get the full story at our sister site, Drug Delivery Business News. The post First patient treated w...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Surgical CSA Medical Inc. Source Type: news

CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the past few years, studies have underscored the potential risk for Barrett’s esophagus with low grade dysplasia to progress to esophageal adenocarcinoma. Intervening at this level of dysplasia has become common practice and is recogni...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance CSA Medical Inc. Source Type: news

CSA Medical wins expanded FDA nod for TruFreeze system
Endoscopic cryo-ablation company CSA Medical said today it won FDA 510(k) clearance for a 3rd spray kit, the rapid AV spray kit, for its TruFreeze system. The Boston-based company’s TruFreeze system is designed as a cryosurgical tool designed for use in dermatology, gynecology, general surgery and to ablate benign and malignant lesions. The newly cleared addition is designed to shorten the time to liquid nitrogen spray by 50%, the company said. The company touted the TruFreeze device as the only ablation technology designed to ablate Barrett’s Esophagus with a high grade dysplasia or cancers as such a...
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Catheters Food & Drug Administration (FDA) Regulatory/Compliance CSA Medical Inc. Source Type: news

DR ELLIE CANNON: I'm warming to cryosurgery to fix my foot  
Morton's neuroma is a very painful and incapacitating condition that affects one of the nerves running between the toes. It tends to happen to women over 40 with a history of wearing high-heel shoes. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2016 Category: Consumer Health News Source Type: news

Cryoablation Successfully Treats Recurrent Mesothelioma
Radiologists at the UCLA Medical Center are successfully killing tumor cells with extreme cold, also known as cryoablation, in patients with recurrent pleural mesothelioma. An outpatient procedure with few complications, cryoablation freezes the localized tumors with argon gas or liquid nitrogen, allowing patients to fight the almost-inevitable cancer recurrence after surgery. Dr. Fereidoun Abtin, a UCLA radiologist who performs the procedure, told Asbestos.com he is “convinced it works well for these patients.” “The results have been impressive, a lot better than what else is out there in the literature ...
Source: Asbestos and Mesothelioma News - December 6, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cryoablation for cancer cryoablation for mesothelioma cryosurgery for mesothelioma cryotherapy for mesothelioma freezing cancer tumors mesothelioma treatment Source Type: news

Cross Creek Animal Medical Centre Introduces Cryosurgery Option for Tampa Pets
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - September 14, 2015 Category: Pharmaceuticals Source Type: news

Ingenol mebutate helped clear actinic keratoses
Cryosurgery followed by topical ingenol mebutate cleared extensive regions of actinic keratosis, which helped reveal residual squamous cell carcinomas, according to a report in the August issue of the Journal of Drugs in Dermatology. The findings show that ingenol mebutate can clear multiple AKs... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 21, 2015 Category: Dermatology Source Type: news

2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer Center New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the ...
Source: Kidney Cancer Association - May 11, 2015 Category: Urology & Nephrology Source Type: news

2015 Conquer Cancer Foundation of ASCO Young Investigator Award
Layperson Summary  New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the anti-body binds to CTLA-4, the immune system is able to stay activated an...
Source: Kidney Cancer Association - May 10, 2015 Category: Cancer & Oncology Source Type: news

Adding ingenol mebutate after cryosurgery enhances clearance of actinic keratoses
Read the full story on MD Consult: Adding ingenol mebutate after cryosurgery enhances clearance of actinic keratoses (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - July 21, 2014 Category: Journals (General) Source Type: news

Cryoablation and nanoparticle-encapsulated anticancer drug combined to destroy cancer stem-like cells
Combining nanodrug-based chemotherapy and cryoablation provides an effective strategy to eliminate cancer stem-like cells (CSCs) the root of cancer resistance and metastasis, which will help to improve the safety and efficacy of treating malignancies that are refractory to conventional therapies.Cryoablation (also called cryosurgery or cryotherapy) is an energy-based, minimally invasive surgical technique that has been investigated to treat a variety of diseases including cancer, which is done by freezing the diseased tissue to subzero temperature to induce irreversible damage. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 16, 2014 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cancer stem cells destroyed with cryoablation and nanoparticle-encapsulated anticancer drug
Combining nanodrug-based chemotherapy and cryoablation provides an effective strategy to eliminate cancer stem-like cells -- the root of cancer resistance and metastasis, which will help to improve the safety and efficacy of treating malignancies that are refractory to conventional therapies. Cryoablation (also called cryosurgery or cryotherapy) is an energy-based, minimally invasive surgical technique that has been investigated to treat a variety of diseases including cancer, which is done by freezing the diseased tissue to subzero temperature to induce irreversible damage. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2014 Category: Science Source Type: news

LEO Pharma announce the completion of the Phase III FIELD Study 1, evaluating one year treatment outcomes of actinic keratosis
LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel. The study involved more than 300 patients across 35 trial sites and is also the first to evaluate field treatment with ingenol mebutate gel subsequent to cryosurgery. LEO Pharma reported that the study met its efficacy and safety endpoints at 11 weeks and 12 months... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 30, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news

VIDEO: Non-Surgical Treatment of Kidney Cancer
Dr. Kamran Ahmar of the M.D. Anderson Cancer Center in Houston, Texas, discusses the use of two methods of dealing with kidney tumors that can be done with tiny probes inserted through the skin guided by imaging to destroy the tumor tissue -- Radio frequency ablation (using heat) and cryosurgery (using freezing).04/23/2011 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - April 23, 2011 Category: Urology & Nephrology Source Type: news